Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IL/Round Lake Beach
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Round Lake Beach, IL

Studies commonly pay $75 to $4,500 per completed study

455 clinical trials are currently recruiting participants within 30 miles of Round Lake Beach. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

455studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Round Lake Beach right now

Top 25 of 455 recruiting studies, sorted by proximity — each links to its official registry page

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

Obesity Phase 3 Interventional 600 participants sought
Endeavor Health — Skokie, Illinois (29.8 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07503210)

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,524 participants sought
Midwestern Regional Medical Center — Zion, Illinois (13.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07200830)

Zenith® Fenestrated+ Clinical Study

Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm N/A Interventional 105 participants sought
Endeavor Health Cardiovascular Institute at Glenbrook Hospital — Glenview, Illinois (26.1 mi) · Sponsor: Cook Research Incorporated
See eligibility & contact on ClinicalTrials.gov (NCT04875429)

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Systemic Lupus Erythematosus Phase 3 Interventional 550 participants sought
Robert A Hozman MD SC — Skokie, Illinois (29.8 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06133972)

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Ulcerative Colitis, Crohn's Disease Phase 3 Interventional 240 participants sought
Advocate Children's Hospital - Park Ridge - PIN — Park Ridge, Illinois (28.2 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT05442567)

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Atherosclerotic Cardiovascular Disease (ASCVD) Phase 3 Interventional 340 participants sought
Advocate Lutheran General Childrens Hospital — Park Ridge, Illinois (28.2 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06813911)

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

Benign Prostatic Hyperplasia N/A Observational 300 participants sought
NorthShore University HealthSystem Research Institute — Glenview, Illinois (26.1 mi) · Sponsor: Northwestern University
See eligibility & contact on ClinicalTrials.gov (NCT05898932)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
Northwestern Medicine Lake Forest Hospital — Lake Forest, Illinois (14.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — Park Ridge, Illinois (28.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07391657)

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Hematologic Malignancies Phase 1, Phase 2 Interventional 160 participants sought
City of Hope - Chicago — Zion, Illinois (13.5 mi) · Sponsor: Sellas Life Sciences Group
See eligibility & contact on ClinicalTrials.gov (NCT04588922)

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Non-Small-Cell Lung Cancer, Metastatic Non-Small-Cell Lung Cancer Phase 3 Interventional 480 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (20.7 mi) · Sponsor: ArriVent BioPharma, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07185997)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought
Northwestern Medicine Lake Forest Hospital — Lake Forest, Illinois (14.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05136196)

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Atopic Dermatitis Phase 3 Interventional 180 participants sought
Endeavor Health Clinical Trials Center — Skokie, Illinois (29.8 mi) · Sponsor: Organon and Co
See eligibility & contact on ClinicalTrials.gov (NCT07265479)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Advocate Children's Hospital-Park Ridge — Park Ridge, Illinois (28.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Phase 3 Interventional 582 participants sought
Research Site — North Chicago, Illinois (12.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06350097)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
Forefront Dermatology — Libertyville, Illinois (9.3 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06548360)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Northwestern Medicine Grayslake Outpatient Center — Grayslake, Illinois (3.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
AMG Libertyville - Oncology — Libertyville, Illinois (9.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma Phase 3 Interventional 720 participants sought
Research Site — Zion, Illinois (13.5 mi) · Sponsor: Arcus Biosciences, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07011719)

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

Recurrent or Metastatic Solid Tumors Phase 2 Interventional 520 participants sought
Orchard Healthcare Research Inc. — Skokie, Illinois (29.8 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT06330064)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
NorthShore University HealthSystem-Highland Park Hospital — Highland Park, Illinois (19.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Northwestern Medicine Grayslake Outpatient Center — Grayslake, Illinois (3.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

Chronic Low-back Pain, Vertebrogenic Pain Syndrome N/A Observational 1,500 participants sought
Illinois Bone and Joint Institute — Barrington, Illinois (15.8 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06827262)
Google-rated

Top-rated research centers in Round Lake Beach

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

AbbVie Clinical Pharmacology Research Unit

★ 3.7
480 US-45, Grayslake, IL 60030
(800) 827-2778
"I like it super friendly and professional at the same time. It's a place for clinical trials"
— Richard Reed, 5★

Innovative Clinical Research Center

★ 2.3
521 Kora Ln, Island Lake, IL 60042
"On March, 11 2024 I had a Urinary tract problem which they asked me to send results to a lab, and getting medication the same day, but that medicatio…"
— Jared Avitia, 1★

Capstone Clinical Research, Inc

1880 W Winchester Rd Ste 204, Libertyville, IL 60048
(847) 549-7214

Clinical Investigation Specialists, Inc. (CIS Research)

★ 4.0
6475 W Washington St Ste 103, Gurnee, IL 60031
(847) 599-2492
"I can't say enough about the exceptional care provided by CIS. The staff is incredibly friendly and professional, always treating patients with the u…"
— Polya Braykova, 5★

Elevate Clinical Research - Chicago

15 Tower Ct Ste 265, Gurnee, IL 60031
(847) 200-5069

Chicago Clinical Research Institute, Inc.

★ 5.0
611 W Roosevelt Rd, Chicago, IL 60607
(312) 823-6800

New Life Clinical Research llc

★ 5.0
(847) 454-3872
"I am deeply grateful to Ekta Grewal for her incredible support throughout my journey in the NLCR program. Not only did she provide me with a partial …"
— Brianna Oppong-Antwi, 5★

Advanced Clinical

★ 5.0
6 Parkway N Ste 100, Deerfield, IL 60015
(847) 267-1176

Clinical Investigation Specialists, Inc. (CIS Research)

★ 4.9
5017 Green Bay Rd #138, Kenosha, WI 53144
(262) 925-1280
"Great staff very knowable and friendly"
— mishelle Pudelek, 5★

Clinical trials in Round Lake Beach: what's recruiting

The Round Lake Beach area currently has 455 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Round Lake Beach, the most active research areas are:

  • Cancer & Oncology13 studies
  • Immune & Skin3 studies
  • Liver & Kidney2 studies
  • Heart & Vascular2 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Round Lake Beach, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Round Lake Beach

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Round Lake Beach participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Round Lake Beach safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Round Lake Beach, IL?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Round Lake Beach?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Round Lake Beach?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Round Lake Beach.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Round Lake Beach typically complete one or two studies per year.

Paid clinical trials near Round Lake Beach

Other metros within reach

Naperville, IL2,362 Aurora, IL617 Chicago, IL2,449 Milwaukee, WI693 Joliet, IL521 Rockford, IL115 Madison, WI520 Appleton, WI152

More of IL

Chicago2,449 Naperville2,362 Aurora617 Joliet521 Peoria219 Springfield192 Champaign167 Rockford115

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts